Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Temozolomide in the Treatment of Children With High Grade Glioma

NCT00028795 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00028795
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00028795 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Temozolomide in the Treatment of Children With High Grade Glioma
Lead sponsor
Children's Oncology Group
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2002
Completion date
March 31, 2012
Enrollment
170 (actual)
Sites
230

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors